Barry Ticho - 15 Mar 2026 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jonathan Allan, Attorney-in-Fact
Issuer symbol
STOK
Transactions as of
15 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 17:25:20 UTC
Previous filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ticho Barry CHIEF MEDICAL OFFICER C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD /s/ Jonathan Allan, Attorney-in-Fact 17 Mar 2026 0001780088

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Options Exercise +13,100 +66% $0.000000* 32,898 15 Mar 2026 Direct
transaction STOK Common Stock Options Exercise +10,000 +30% $0.000000* 42,898 15 Mar 2026 Direct
transaction STOK Common Stock Options Exercise +10,750 +25% $0.000000* 53,648 15 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Restricted Stock Units Options Exercise -13,100 -50% $0.000000* 13,100 15 Mar 2026 Common Stock 13,100 Direct F1, F2
transaction STOK Restricted Stock Units Options Exercise -10,000 -33% $0.000000* 20,000 15 Mar 2026 Common Stock 10,000 Direct F1, F3
transaction STOK Restricted Stock Units Options Exercise -10,750 -25% $0.000000* 32,250 15 Mar 2026 Common Stock 10,750 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
F2 The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date.
F3 The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the Issuer through each vesting date.
F4 The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date.